The 61st ASH Annual Meeting: Unwrapping the Best From Hematology's Christmas
2019 ASH News Daily Editor Dr. Ayesha Zia recaps the 61st ASH Annual Meeting and Exposition which took place early December in Orlando.
Act Fast! Making a Difference After Traumatic Brain Injury With Tranexamic Acid
Dr. Tseng discusses several studies that investigate the efficacy and safety of tranexamic acid in patients with traumatic brain injury.
A concise review of a topic that illustrates the relationship of basic research to clinical hematology
Drs. Laura Calvi and Jane Liesveld discuss the current understanding of the role of the bone marrow microenvironment in myelodysplastic syndromes to advocate for novel therapeutic opportunities targeting the microenvironment.
Dr. Boddu and Dr. Zeidan discuss therapy-related myeloid disease after autoimmune illness.
Dr. Siok-Keen Tey and Dr. Geoffrey Hill explore therapeutic options for treating chronic graft-versus-host disease.
Dr. David Sallman reviews studies that show the profound negative connotation of TP53 mutation in myelodysplastic syndromes and the immediate need for effective, biologically rational, targeted therapies.
Dr. Sheth discusses advances in therapies for β-thalassemia syndromes including optimization of gene therapy and the use of agents that leverage molecular targets.
Dr. Jenny Despotovic covers the expanded therapeutic repertoire currently emerging to treat immune thrombocytopenia (ITP) as understanding of ITP disease biology improves.
Dr. Jordan examines the emergence of targeted therapy for hemophagocytic lymphohistiocytosis, a striking inflammatory disorder familiar to hematologists.
Dr. Paneez Khoury provides an overview of the diagnosis and treatment of lymphocytic variant hypereosinophilic syndromes.
Dr. Schiffman and Dr. Maese discuss pediatric cancer susceptibility disorders and their relevance to hematology as highlighted in a 2016 American Association for Cancer Research workshop.
Dr. Abdel-Wahab provides an overview of histiocytoses or histiocytic neoplasms, some of the most challenging hematologic disorders to diagnose and categorize.
January-February 2020Volume 17, Issue 1
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology